Pedro Marques da Silva

Summary

Country: Portugal

Publications

  1. doi Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan
    Pedro Marques da Silva
    Núcleo de Investigação Arterial, Medicina IV Hospital de Sta Marta, CHLC, EPE, Lisbon, Portugal
    Clin Drug Investig 30:625-41. 2010
  2. doi Persistent lipid abnormalities in statin-treated patients: Portuguese diabetic subpopulation of the Dyslipidaemia International Study (DYSIS)
    Pedro Marques da Silva
    Arterial Investigation Unit, Internal Medicine 4 Department, Hospital Santa Marta, Rua de Santa Marta, 1169 1024 Lisbon, Portugal Electronic address
    Prim Care Diabetes 9:283-9. 2015
  3. ncbi [Intensive cholesterol drug lowering: how to be sure about their safety]
    Pedro Marques da Silva
    Unidade Funcional Medicina IV do Hospital de Santa Marta Centro Hospitalar de Lisboa Central, EPE, Lisboa, Portugal
    Rev Port Cardiol 29:1405-18. 2010
  4. doi Are all statins the same? Focus on the efficacy and tolerability of pitavastatin
    Pedro Marques da Silva
    Núcleo de Investigação Arterial, Medicina IV Hospital de Sta Marta, CHLC, EPE, Lisbon, Portugal
    Am J Cardiovasc Drugs 11:93-107. 2011

Collaborators

  • Pedro Marques da Silva
  • António Miguel Ferreira
  • Salvador Massano Cardoso

Detail Information

Publications4

  1. doi Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan
    Pedro Marques da Silva
    Núcleo de Investigação Arterial, Medicina IV Hospital de Sta Marta, CHLC, EPE, Lisbon, Portugal
    Clin Drug Investig 30:625-41. 2010
    ....
  2. doi Persistent lipid abnormalities in statin-treated patients: Portuguese diabetic subpopulation of the Dyslipidaemia International Study (DYSIS)
    Pedro Marques da Silva
    Arterial Investigation Unit, Internal Medicine 4 Department, Hospital Santa Marta, Rua de Santa Marta, 1169 1024 Lisbon, Portugal Electronic address
    Prim Care Diabetes 9:283-9. 2015
    ..To assess the treatment patterns and prevalence of persistent lipid abnormalities in Portuguese statin-treated patients with diabetes...
  3. ncbi [Intensive cholesterol drug lowering: how to be sure about their safety]
    Pedro Marques da Silva
    Unidade Funcional Medicina IV do Hospital de Santa Marta Centro Hospitalar de Lisboa Central, EPE, Lisboa, Portugal
    Rev Port Cardiol 29:1405-18. 2010
    ..The grounds for treatment and intensive effective reduction of dyslipidemias must be made through a better adherence to quality Health Programs and through improving treatment and achieved goals...
  4. doi Are all statins the same? Focus on the efficacy and tolerability of pitavastatin
    Pedro Marques da Silva
    Núcleo de Investigação Arterial, Medicina IV Hospital de Sta Marta, CHLC, EPE, Lisbon, Portugal
    Am J Cardiovasc Drugs 11:93-107. 2011
    ..The combination of a potent decrease in total and LDL cholesterol levels and increase in HDL cholesterol levels suggest that pitavastatin may produce substantial cardiovascular protection...